Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Dimensional World ex U.S. Core Equity 2 ETF
(NY:
DFAX
)
32.38
+0.24 (+0.75%)
Official Closing Price
Updated: 8:00 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dimensional World ex U.S. Core Equity 2 ETF
< Previous
1
2
Next >
Tilray Stock On Track For Near 2-Month High As 'Weednesday' Buzz Builds Around Trump Cannabis Order — Retail Eyes Massive Upside
↗
December 16, 2025
Via
Stocktwits
Topics
Cannabis
Government
Stellantis CEO Says New Engine, Vehicle Models Will Drive ‘Progressively Better’ Demand
↗
December 04, 2025
Filosa said that the company is on track on its full year guidance through the end of November.
Via
Stocktwits
Topics
Government
World Trade
Li Auto Posts Unexpected Loss In Q3 As EV Sales Drop
↗
November 26, 2025
CEO Xiang Li highlighted challenges pertaining to the supply chain and product lifecycle, among others.
Via
Stocktwits
Topics
Economy
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study
↗
November 25, 2025
Via
Stocktwits
BABA Stock Rises Pre-Market As AI-Driven Cloud Growth Drives Revenue Beat
↗
November 25, 2025
Via
Stocktwits
Novo Nordisk’s Blockbuster Drug Fails To Slow Alzheimer’s Disease Progression In Studies
↗
November 24, 2025
The company said that it is discontinuing the trials.
Via
Stocktwits
Novo’s Obesity Drug Patients Granted Compensation In Denmark Over Rare Eye Disease Linked To Wegovy, Ozempic
↗
November 21, 2025
Via
Stocktwits
Toyota Commits Up To $10B Additional Investments In US Over Five Years
↗
November 12, 2025
Via
Stocktwits
Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence
↗
November 10, 2025
Via
Stocktwits
Takeda Pharmaceuticals’ Genetic Disease Therapy Under FDA Probe After Pediatric Patient Dies
↗
November 21, 2025
The death of a pediatric congenital thrombotic thrombocytopenic purpura patient appears to be related to Adzynma, the FDA said.
Via
Stocktwits
Novo Nordisk Brings Back Former CEO To Lead Board
↗
November 14, 2025
Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday.
Via
Stocktwits
Stellantis NV Recalls Over 320,000 Jeep Plug-In Hybrids In US Over Fire Risk
↗
November 04, 2025
The recall includes certain model year 2020- 2025 Jeep Wrangler 4Xe and model year 2022-2026 Grand Cherokee 4Xe plug-in hybrid vehicles.
Via
Stocktwits
Topics
Product Recall
Alibaba’s AI Glasses To Be Priced At $659, Pre-Sale On October 24 On Its E-commerce Platform Tmall: Report
↗
October 23, 2025
According to a CNBC report, the price of the product, known as Quark AI Glasses, during pre-sale would be 4,699 yuan.
Via
Stocktwits
Topics
Artificial Intelligence
AstraZeneca Unveils Expanded Facility In Texas Aimed At Doubling Production Of Hyperkalemia Drug
↗
October 15, 2025
The facility in Coppell, which employs more than 250 people, is the sole global manufacturing facility for the company’s Lokelma.
Via
Stocktwits
AstraZeneca Announces $4.5B Investment In Virginia
↗
October 09, 2025
Via
Stocktwits
AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure
↗
September 29, 2025
Via
Stocktwits
US Regulator Closes Probe Into Stellantis’ 24,000 Alfa Romeo Giulia Vehicles
↗
September 29, 2025
Via
Stocktwits
US FDA Alleges Novo Nordisk’s Video On Weight-loss Drugs Featuring Oprah Winfrey Is ‘False Or Misleading’
↗
September 16, 2025
Via
Stocktwits
Novo Nordisk Says New Obesity Treatment Achieved 11.8% Body Weight Reduction In Late-stage Study
↗
September 16, 2025
Via
Stocktwits
Stellantis Recalls Nearly 54,000 Vehicles In US Over Concerns Regarding Fuel Pump: But Retail Sees Stock Rallying To $10 This Week
↗
September 16, 2025
Via
Stocktwits
Topics
Product Recall
Eli Lilly, Novo Nordisk Preparing To Introduce Obesity Pills Next Year In The US: Report
↗
September 12, 2025
Via
Stocktwits
Toyota Recalls Over Half A Million Vehicles In The US
↗
September 11, 2025
Via
Stocktwits
Topics
Product Recall
Ford Supplier Magna International Appoints Former Timken Executive As CFO
↗
September 11, 2025
Via
Stocktwits
Topics
Supply Chain
Stellantis Stock Slips After US Regulator Probes 287,000 Chrysler Minivans Over Concerns Regarding Electric Power Steer
↗
September 08, 2025
Via
Stocktwits
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More
↗
September 04, 2025
Via
Stocktwits
Citi Lowers Price Target On This Chinese EV Maker After Disappointing Q3 Guidance: Retail Expects Shares To ‘Eventually Implode’
↗
August 29, 2025
Via
Stocktwits
This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More
↗
August 28, 2025
Via
Stocktwits
Stellantis Shells Out $41M More To Expand Its U.S. Parts Distribution Network: More Details Inside
↗
August 27, 2025
Via
Stocktwits
Li Auto Announces Lower Q3 Delivery Outlook Despite New Vehicle Launches: Retail Sees i8, i6 Selling Like ‘Hot Cakes’
↗
August 28, 2025
Li Auto now expects vehicle deliveries to be between 90,000 and 95,000 vehicles, representing a year-over-year decrease of 41.1% to 37.8%.
Via
Stocktwits
Topics
Earnings
This Pharma Major’s Stock Has Lost 59% Of Its Value In A Year – Why Is It Drawing Investor Interest Today?
↗
August 28, 2025
Novo Nordisk has entered into a collaboration with Replicate BioScience under which it will receive a defined, exclusive, worldwide license to use the latter’s self-replicating RNA platform to develop...
Via
Stocktwits
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.